Participants:18–64 years · 65+ years
Substances:1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One

Contact Research Centre

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Baricitinib

Contact Research Centre

IgA nephropathy

Not recruiting

Investigational

Study on Sibeprenlimab for Patients with IgA Nephropathy

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Sibeprenlimab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Squamous cell carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer stage I+1

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 27

346 trials match your criteria

Psoriasis

Study on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms

Pyoderma gangrenosum

Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

Hypoparathyroidism

Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

Bladder cancer+2

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Dyslipidaemia

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Lung disorder

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

IgA nephropathy

Study on Sibeprenlimab for Patients with IgA Nephropathy

Squamous cell carcinoma of head and neck

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Plasma cell myeloma

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Squamous cell carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Non-small cell lung cancer stage I+1

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.